Mitochondrial dysfunction induced by callyspongiolide promotes autophagy-dependent cell death
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Callyspongiolide is a marine macrolide known to induce caspaseindependent cancer cell death. While its toxic effects have been known, the mechanism leading to cell death is yet to be identified. We report that Callyspongiolide R form at C-21 (cally2R) causes mitochondrial dysfunction by inhibiting mitochondrial complex I or II, leading to a disruption of mitochondrial membrane potential and a deprivation of cellular energy. Subsequently, we observed, using electron microscopy, a drastic formation of autophagosome and mitophagy. Supporting these data, LC3, an autophagosome marker, was shown to co-localize with LAMP2, a lysosomal protein, showing autolysosome formation. RNA sequencing results indicated the induction of hypoxia and blocking of EGF-dependent pathways, which could be caused by induction of autophagy. Furthermore, mTOR and AKT pathways preventing autophagy were repressed while AMPK was upregulated, supporting autophagosome progress. Finally, the combination of cally2R with known anti-cancer drugs, such as gefitinib, sorafenib, and rapamycin, led to synergistic cell death, implicating potential therapeutic applications of callyspongiolide for future treatments.
Abstract
Callyspongiolide is a marine macrolide known to induce caspaseindependent cancer cell death. While its toxic effects have been known, the mechanism leading to cell death is yet to be identified. We report that Callyspongiolide R form at C-21 (cally2R) causes mitochondrial dysfunction by inhibiting mitochondrial complex I or II, leading to a disruption of mitochondrial membrane potential and a deprivation of cellular energy. Subsequently, we observed, using electron microscopy, a drastic formation of autophagosome and mitophagy. Supporting these data, LC3, an autophagosome marker, was shown to co-localize with LAMP2, a lysosomal protein, showing autolysosome formation. RNA sequencing results indicated the induction of hypoxia and blocking of EGF-dependent pathways, which could be caused by induction of autophagy. Furthermore, mTOR and AKT pathways preventing autophagy were repressed while AMPK was upregulated, supporting autophagosome progress. Finally, the combination of cally2R with known anti-cancer drugs, such as gefitinib, sorafenib, and rapamycin, led to synergistic cell death, implicating potential therapeutic applications of callyspongiolide for future treatments.
참고문헌 (23)
- Linder B, "Autophagy in cancer cell death", Biology(Basel), 8, pp.82~ (2019)
- Akkoc Y, "Autophagy and liver cancer", Turk J Gastroenterol, 29, pp.270~282 (2018)
- Kim SY, "Coptisine induces autophagic cell death through down-regulation of PI3K", Akt, Arch Biochem Biophys, pp.2021, 697[DOI]
- Sanchez-Alvarez M, "Sestrins as a therapeutic bridge between ROS and autophagy in cancer", Cancers(Basel), 11, pp.1415~ (2019)
- Bao J, "The prospects of therapeutic potential and drug development targeting autophagy in cancer", Adv Exp Med Biol, 1207, pp.663~679 (2020)
- Nyfeler B, "Revisiting autophagy addiction of tumor cells", Autophagy, 12, pp.1206~1207 (2016)
- Vander Heiden MG, "Understanding the Warburg effect : the metabolic requirements of cell proliferation", Science, 324, pp.1029~1033 (2009)
- Bernardi P, "Mitochondrial transport of cations : channels, exchangers, and permeability transition", Physiol Rev, 79, pp.1127~1155 (1999)
- Faubert B, "The AMP-activated protein kinase(AMPK)and cancer : many faces of a metabolic regulator", Cancer Lett, 356, pp.165~170 (2015)
- Vyas S, "Mitochondria and cancer", Cell, 166, pp.555~566 (2016)
- Toyama EQ, "Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress", Science, 351, pp.275~281 (2016)
- Pham CD, "Callyspongiolide, a cytotoxic macrolide from the marine sponge Callyspongia sp", Org Lett, 16, pp.266~269 (2014)
- Pommier Y, "Apoptosis defects and chemotherapy resistance : molecular interaction maps and networks", Oncogene, 23, pp.2934~2949 (2004)
- Chang YH, "Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia", Am J Cancer Res, 5, pp.1844~1853 (2015)
- Manoni F, "Unconventional fragment usage enables a concise total synthesis of(-)-callyspongiolide", J Am Chem Soc, 140, pp.1280~1284 (2018)
- Wang Y, "Metformin induces autophagy and G0", G1 phase cell cycle arrest in myeloma by targeting the AMPK, J Exp Clin Cancer Res, pp.2018, 37[DOI]
- Bjorkoy G, "Monitoring autophagic degradation of p62", SQSTM1, 2009, pp.452, 181~197
- Fernandez-Marcos PJ, "Mitochondrial damage induces senescence with a twisted arm", Cell Metab, 23, pp.229~230 (2016)
- Ahmad M, "Biochemistry, electron transport chain" (2021), StatPearls Publishing
- Agani FH, "The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia", J Biol Chem, 275, pp.35863~35867 (2000)
- Huang Y, "Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways", Cancer Commun(Lond), 38, pp.50~ (2018)
- Fogarty S, "Callyspongiolide Is a potent inhibitor of the vacuolar ATPase", J Nat Prod, 83, pp.3381~3386 (2020)
- Fethiere J, "Building the stator of the yeast vacuolar-ATPase : specific interaction between subunits E and G", J Biol Chem, 279, pp.40670~40676 (2004)